Texas

Resilience System


You are here

Opinion: As the COVID emergency ends, monoclonal antibodies remain essential

Primary tabs

...

Monoclonal antibodies (mAbs) — laboratory-grown proteins that work like natural antibodies to help the body fight illness — have been a valuable tool for treating COVID in this population. Monoclonal products such as bamlanivimabcasirivimab and imdevimab (which are administered together) and sotrovimab were found to be particularly beneficial in reducing the risk of hospitalization and death for the estimated 3 percent of Americans with weakened immune systems. In addition to reducing the severity of infections, mAbs have been shown to help prevent COVID among the immunocompromised and in the general population.  

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 
Groups this Group Post belongs to: 
- Private group -
howdy folks
Page loaded in 0.431 seconds.